Regulation of glucose transport in human skeletal muscle

References

• Kahn CR. Insulin action, diabetogenes, and the cause of Type II diabetes. Diabetes 1994; 43: 1066–84.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. The Triumvirate: I3-cell, muscle or liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667–87.
   PubMed Web of Science ®Google Scholar
• Vaag A, Henriksen JE, Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscle in young nonobese caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 782–8.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Jocot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Diabetes 1981; 30: 1000–7.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Gunnarsson R, Björkman 0, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (Type II) dia-betes mellitus. J Clin Invest 1985; 76: 149–55.
   PubMed Web of Science ®Google Scholar
• Eriksson J, Koranyi L, Bourey R, Schalin C, Widen E, Mueckler M et al. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT4) gene in human skeletal muscle. Diabetologia 1992; 35: 143–7.
   PubMedGoogle Scholar
• Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322: 223–8.
   PubMed Web of Science ®Google Scholar
• Henriksen JE, Alford F, Handberg A, Vaag A, Ward GM, Kalfas A, et al. Increased glucose effectiveness in normogly- cemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 94: 1196–204.
   PubMedGoogle Scholar
• Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 1999; 341: 240–6.
   PubMed Web of Science ®Google Scholar
• Dohm GL, Tapscott EB, Pories WJ, Dabbs DJ, Flickinger EG, Meelheim D, et at. An in vitro human skeletal muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest 1988; 82: 486–94.
   PubMed Web of Science ®Google Scholar
• Zierath JR, Galuska D, Engstrom A, Johnson KH, Betsholtz C, Westennark P, et al. Human islet amyloid polypeptide at pharmacological levels inhibit insulin and phorbol ester-stimulated glucose transport in in vitro incu-bated human skeletal muscle strips. Diabetologia 1992; 35: 26–31.
   PubMed Web of Science ®Google Scholar
• Andréasson K, Galuska D, Thome A, Sonnenfeld T, Wall- berg-Henriksson H. Decreased insulin-stimulated 3-0- methylglucose transport in in vitro incubated muscle strips from type II diabetic subjects. Acta Physiol Scand 1991; 142: 255–60.
   PubMedGoogle Scholar
• Krook A, Björnholm M, Galuska D, Jiang X-J, Fahlman R, Myers Jr. MG, et at. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 284–92.
   PubMed Web of Science ®Google Scholar
• Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999; 48: 1807–14.
   PubMed Web of Science ®Google Scholar
• Kasuga M, Hedo JA, Yamada KM, Kahn CR. Structure of insulin receptor and its subunits. J Biol Chem 1982; 257: 10392–9.
   PubMedGoogle Scholar
• Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991; 352: 73–7.
   PubMed Web of Science ®Google Scholar
• Sun XJ, Wang LM, Zhang Y, Yenush L, Myers Jr. MG, Glasheen E, et at. Role of IRS-2 in insulin and cytokine signalling. Nature 1995; 377: 173–7.
   PubMed Web of Science ®Google Scholar
• Lavan BE, Lane WS, Lienhard GE. The 60-kDa phosphoty- rosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 1997; 272: 11439–43.
   PubMed Web of Science ®Google Scholar
• Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE. A novel 160-kpa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 1997; 272: 21403–7.
   PubMed Web of Science ®Google Scholar
• Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ. A Grb-2-associated docking protein in EGF-and insulin-receptor signalling. Nature 1996; 379: 560–4.
   PubMed Web of Science ®Google Scholar
• Ribon V, Saltiel AR. Insulin stimulates tyrosine phosphoryl- ation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes. Biochem J 1997; 324: 839–45.
   PubMed Web of Science ®Google Scholar
• White ME The insulin signalling system: A network of docking proteins that mediate insulin action. Mol Cell Biochem 1998; 182: 3–11.
   PubMedGoogle Scholar
• Lund S, Holman GD, Schmitz 0, Pedersen 0, Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 1995; 92: 5817–21.
   PubMed Web of Science ®Google Scholar
• Shepherd PR, Nave BT, Rincon J, Haigh RI Foulstone E, Proud C, et al. Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: Implications for glucose metabolism. Diabetologia 1997; 40: 1172–7.
   PubMedGoogle Scholar
• Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PRI Reese CB, et al. Characterization of a 3-phosphoinosi- tide-dependent protein kinase which phosphorylates and activates protein kinase Ba. Curr Biol 1997; 7: 261–9.
   Google Scholar
• Nakanishi H, Brewer KA, Exton JH. Activation of the isoenzyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1993; 268: 13–6.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay G, Standaert ML, Zhao L, Yu B, Avignon A, Galloway L, et al. Activation of Protein Kinase C (a, 13, andby insulin in 3T3/L1 cells: Transfection studies suggest a role for PKC-C in glucose transport. J Biol Chem 1997; 272: 2551–8.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert ML, Quon MI Lea-Currie R, et al. pKC- mediates insulin effects on glucose transport in cultured preadipocyte-derived human adipocytes. J Clin Endocrinol Metab 2002; 87: 716–23.
   PubMed Web of Science ®Google Scholar
• Krook A, Whitehead JP, Dobson SP, Griffiths MR, Ouwens M, Baker C, et al. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phos-phatidylinositol 3-kinase activation alone is not sufficient for the meditation of insulin's metabolic and mitogenic effects. J Biol Chem 1997; 272: 30208–14.
   PubMedGoogle Scholar
• Jiang T, Sweeney G, Rudolf MT, Klip A, Traynor-Kaplan A, Tsien RY. Membrane-permeant esters of phosphatidylino- sitol 3,4,5-trisphosphate. J Biol Chem 1998; 273: 11017–24.
   PubMed Web of Science ®Google Scholar
• Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000; 407: 147–8.
   PubMedGoogle Scholar
• Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Neudauer CL, et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001; 410: 944–8.
   PubMed Web of Science ®Google Scholar
• Maegawa H, Shigeta Y, Egawa K, Kobayashi M. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 1991; 40: 815–9.
   PubMed Web of Science ®Google Scholar
• Klein HH, Vestergaard H, Kotzke G, Pedersen a Elevation of serum insulin concentration during euglycemic hyperinsu- linemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Diabetes 1995; 44: 1310–7.
   PubMedGoogle Scholar
• Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, et al. insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 10: 311–20.
   Google Scholar
• Arner P, PoRare T, Lithell H, Livingston JN. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 437–40.
   PubMed Web of Science ®Google Scholar
• Nolan JJ, Freidenberg G, Henery R, Reichart D, Olefsky Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 1994; 78: 471–7.
   PubMed Web of Science ®Google Scholar
• Caro JF, Sinha MK, Raju SM, Ittoop 0, Pories WJ, Flickinger EG, et al. Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin dependent diabetes. J Clin Invest 1987; 79: 1330–7.
   PubMed Web of Science ®Google Scholar
• Goodyear 14, Giorgino F, Sherman LA, Carey J, Smith RJ, Dolun GI- Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 1995; 95: 2195–204.
   Google Scholar
• Shao J, Yamashita H, Qiao L, Draznin B, Friedman JE. Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. Diabetes 2002; 51: 19–29.
   PubMedGoogle Scholar
• Bjömhohn M, Kawano Y, Lehtihet M, Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in skeletal muscle from NIDDM subjects following in vivo insulin stimulation. Diabetes 1997; 46: 524–7.
   PubMedGoogle Scholar
• Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 1999; 104: 733–41.
   PubMed Web of Science ®Google Scholar
• Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg- Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from non-insulin-dependent dia-betic subjects. Diabetes 1998; 47: 1281–6.
   PubMed Web of Science ®Google Scholar
• Vollenweider P, Menard B, Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidy- linosito1-3' kinase activation, and impaired atypical protein kinase CA) activation in myotubes from obese patients with impaired glucose tolerance Diabetes 2002; 51: 1052–9.
   Google Scholar
• Douen AG, Ramlal T, Rastogi SA, Bilan PJ, Cartee GD, Vranic M, et al. Exercise induces recruitment of the "insulin responsive" glucose transporter. Evidence for distinct intra-cellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J Biol Chem 1990; 265: 13427–30.
   PubMedGoogle Scholar
• Hirshman MF, Goodyear 14, Wardzala 14, Horton ED, Horton ES. Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle. J Biol Chem 1990; 265: 987–91.
   PubMed Web of Science ®Google Scholar
• Dann G, Elton C, Friedman J, Pilch PF, Pories W, Atkinson S, et at. Decreased expression of glucose transporters in muscle from insulin-resistant patients. Am J Physiol Endocri- nol Metab 1991; 260: E459–63.
   Google Scholar
• Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J. Expression of insulin-regulatable glucose transporters in skeletal muscle from Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990; 33: 625–7.
   PubMedGoogle Scholar
• Pedersen 0, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, et at. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 1990; 39: 865–70.
   PubMed Web of Science ®Google Scholar
• Guma A, Zierath JR, Wallberg-Henriksson H, Klip A. Insulin induces translocation of GLUT-4 glucose transporters in human skeletal muscle. Am J Physiol Endocrinol Metab 1995; 268: E613–22.
   Google Scholar
• Zierath JR, He L, Guma A, Wahlström E, Klip A, Wallberg- Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 1996; 39: 1180–9.
   PubMed Web of Science ®Google Scholar
• Holman GD, Kozka U, Clark AE, Flower CJ, Saltis Habberfield AD, et at. Cell-surface labeling of glucose transporter isoform GLUT4 by Bis-Mannose photolabel: Correlation with stimulation of glucose transport in rat adipose cells by insulin and phorbol ester. J Biol Chem 1990; 265: 18172–9.
   PubMedGoogle Scholar
• Koumanov F, Yang J, Jones AE, Hatanaka Y, Holman GD. Cell-surface biotinylaticn of GLUT4 using bis-mannose photolabels. Biochem J 1998; 330: 1209–15.
   PubMedGoogle Scholar
• Lund S, Holman GD, Zierath JR, Rincon J, Nolte LA, Clark AE, et al. Effect of insulin on GLUT4 translocation and turnover rate in human skeletal muscle as measured by the exofacial bismannose photolabeling technique. Diabetes 1997; 46: 1965–9.
   PubMedGoogle Scholar
• Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, Zierath JR. Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle: Involvement of the mitogen- and stress-activated protein kinase 1. J Biol Chem 2000; 275: 1457–62.
   PubMed Web of Science ®Google Scholar
• Cartee GD, Douen AG, Ramlal T, Klip A, Holloszy JO. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol 1991; 70: 1593–600.
   PubMedGoogle Scholar
• Zierath JR, Tsao T-S, Stenbit AE, Ryder JW, Galuska D, Charron M.J. Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J Biol Chem 1998; 273: 20910–5.
   PubMedGoogle Scholar
• Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, et at. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999; 48: 1192–7.
   PubMedGoogle Scholar
• Zierath JR. In vitro studies of human skeletal muscle. Hormonal and metabolic regulation of glucose transport. Acta Physiol Scand 1995; 155 Suppl. 626): 1–96.
   PubMedGoogle Scholar
• Wallberg-Henriksson H, Constable SH, Young DA, Hol- loszy JO. Glucose transport into rat skeletal muscle: interac-tion between exercise and insulin. J Appl Physiol 1988; 65: 909–13.
   PubMed Web of Science ®Google Scholar
• Ryder JW, Yang J, Galuska D, Rincón J, Björnholm M, Krook A, et at. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia stimu-lated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 647–54.
   PubMed Web of Science ®Google Scholar
• Koistinen HA, Galuska D, Chibalin A, Holman GD, Wallberg-Henriksson H, Zierath JR. AICAR increases glucose transport in isolated skeletal muscle from non-diabetic and type 2 diabetic men. Diabetes 2002; 51: A310.
   Google Scholar
• Brozinick Jr. JT, Birnbaum AV. Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. J Biol Chem 1998; 273: 14679–82.
   PubMedGoogle Scholar
• Lund S, Pryor PR, Ostergaard S, Schmitz 0, Pedersen 0, Holman GD. Evidence against protein kinase B as a mediator of contraction-induced glucose transport and GLUT4 translo-cation in rat skeletal muscle. FEBS Letters 1998; 425: 472–4.
   PubMedGoogle Scholar
• Widegren U, Jiang XJ, Krook A, Chibalin AV, Björnhohn M, Tally M, et at. Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. FASEB J 1998; 12: 1379–89.
   PubMed Web of Science ®Google Scholar
• Goodyear JJ, Giorgino F, Baton TV/, Condorelli G, Smith Effects of contractile activity on tyrosine phosphorylation and PI 3-kinase activity in rat skeletal muscle. Am J Physiol Endocrinol Metab 1995; 268: E987–95.
   PubMedGoogle Scholar
• Hayashi T, Hirshman MF, Kuth EJ, Winder WW, Goodyear U. Evidence for 5'-AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47: 1369–73.
   PubMed Web of Science ®Google Scholar
• Youn JH, Gulve EA, Holloszy JO. Calcium stimulates glucose transport in skeletal muscle by a pathway independent of contraction. Am J Physiol Cell Physiol 1991; 260: C555–61.
   Google Scholar
• Youn JH, Gulve EA, Henriksen EJ, Holloszy JO. Interac- tions between effects of W-7, insulin, and hypoxia on glucose transport in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 1994; 267: R888–94.
   Google Scholar
• Mu J, Brozinick JTJ, Valladares 0, Bucan M, Birnbaum Mi. A role for AMP-activated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 2001; 7: 1085–94.
   PubMed Web of Science ®Google Scholar
• Ponticos M, Lu QL, Morgan JE, Hardie DG, Partridge TA, Carling D. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J 1998; 17: 1688–99.
   PubMed Web of Science ®Google Scholar
• Song X, Fiedler M, Galuska D, Ryder JW, Fernström M, Chibalin AV, et at. 5-aminoimidazole-4-carboxamick ribonu- cleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 2002; 45: 56–65.
   PubMed Web of Science ®Google Scholar
• Musi N, Fujii N, Hirshman MF, Ekberg I, Fröberg S, Ljungqvist 0 et at. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with Type 2 diabetes during exercise. Diabetes 2001; 50: 921–7.
   PubMed Web of Science ®Google Scholar
• Rodgers MA, Yamamoto C, King DS, Hagberg JM, Ehsani AA, Holloszy JO. Improvement in glucose tolerance after 1 wk of exercise in patients with mild NIDDM. Diabetes Care 1988; 11: 613–8.
   PubMedGoogle Scholar
• Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Shepherd PR, et at. Exercise increases muscle GLUT4- levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol Endocrinol Metab 1993; 264: E855–62.
   PubMed Web of Science ®Google Scholar
• Houmard JA, Egan PC, Neufer PD, Friedman JE, Wheeler WS, Israel RG, et at. Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men. Am J Physiol Endocrinol Metab 1991; 261: E437–43.
   PubMed Web of Science ®Google Scholar
• Hjeltnes N, Galuska D, Bjömhohn M, Aksnes A-K, Lannem A, Zierath JR, et al. Exercise-induced overexpres- sion of key regulatory proteins involved in glucose uptake and metabolism in tetraplegic persons: Molecular mechanism for improved glucose homeostasis. FASEB J 1998; 12: 1701–12.
   PubMed Web of Science ®Google Scholar
• Dela F, Handberg A, Mikines KJ, Vinten J, Galbo H. GLUT4 and insulin receptor binding and kinase activity in trained human muscle. J Physiol 1993; 469: 615–24.
   PubMed Web of Science ®Google Scholar
• Yu M, Blomstrand E, Chibalin AV, Krook A, Zierath JR. Marathon running increases ERK1/2 and p38 MAP Kinase signalling to downstream targets in human skeletal muscle. J Physiol 2001; 536: 273–82.
   PubMedGoogle Scholar
• Chibalin AV, Yu M, Ryder JV/, Song XM, Galuska D, Krook A, et al. Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: Differential effects on insulin receptor sub-strates 1 and 2. Proc Natl Acad Sci USA 2000; 97: 38–43.
   PubMed Web of Science ®Google Scholar